Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Allergan Receives FDA Approval For ACUVAIL(TM) Ophthalmic Solution For The Treatment Of Pain And Inflammation Following Cataract Surgery
Allergan, Inc. (NYSE: AGN) announced that the United States Food and Drug Administration (FDA) has approved ACUVAIL(TM) (ketorolac tromethamine ophthalmic solution) 0.45%, an advanced, preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain and inflammation following cataract surgery. Cataracts are a leading cause of blindness among older adults and cataract surgery is the most frequently performed surgical procedure in the United States, with more than 3 million procedures performed each year.1
generic viagra online
Approval For Use Of RISPERDAL CONSTA As Both A Monotherapy And Adjunctive Therapy In The Maintenance Treatment Of Bipolar I Disorder Granted By FDA
Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.
News of the day
Thirteen Single-Payer Activists Settle Their Cases After Disrupting Hearing
Thirteen people charged with "disruption of Congress" for standing and shouting pro-single-payer system slogans during a health care reform committee hearing settled their cases, The Great Falls (Mont.) Tribune reports.
Medical Devices

APEX Guides: Helping PBC Leaders To Become World Class Commissioners

The first three guides - Clinical Engagement, Governance and Prioritising Investment - will be launched at the Practice Based Commissioning National Forum, on 1 July. A fourth guide, on Patient and Public Engagement, will be published over the summer and a fifth, on Procurement, is already in the pipeline and expected to be published in September. APEX recognises that commissioners will have to make tough decisions to bring costs down while focusing on quality. Practice-based commissioning will be crucial in this process by bringing Primary Care Trusts (PCTs) and clinicians together. Dr David Jenner, Practice Based Federation Lead, NHS Alliance, said: "We want to promote the partnership between PBC and PCTs through effective commissioning. The APEX guides will help practice based commissioners develop to become world class commissioners with their PCTs by demonstrating what true world class commissioning would look like in action." Mark Hill, co-chair for APEX and Market Access Director at Novartis UK, said: "I am delighted that Novartis have collaborated with the NHS Alliance to develop these innovative commissioning competency guides. I firmly believe that the APEX guides will foster a productive relationship between PBC and PCTs and help to drive and deliver excellence in WCC". All guides are being developed through focus groups and discussions with key health service professionals. APEX is also currently developing a website which will become a platform for commissioners to share their experience and examples of best practice. NHSA members can download free copies of the guides from the NHS Alliance"s website at http://www.nhsalliance.org Notes 1. APEX is a practical, collaborative network, driving best practice and catalysing positive change for patients through practice-based commissioning (PBC). The APEX membership comprises a multidisciplinary group of PBC leaders who are representative of SHAs, and includes local PBC Group Chairs, SHA Commissioning Heads, and PCT Chief Executives and commissioning directors. Through a series of strategic, action-led initiatives, the aims of APEX are to: - drive best practice and catalyse positive change for patients through practice-based commissioning; - translate the ideas of clinicians into successful plans for PCTs; - help strategic health authorities (SHAs), PCTs and practices turn "talk" into "action", and - demonstrate and pioneer models of collaboration between industry and the NHS. 2. APEX is sponsored by an unrestricted grant by Novartis Pharmaceuticals Ltd APEX


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009